EverQuote repurchases 900,000 shares from chairman's entities

EverQuote (NASDAQ:EVER) has agreed to repurchase 900,000 shares of its Class A common stock for $21 million ($23.33/share, a discount to market) from entities affiliated with co-founder David Blundin, as part of its $50 million share repurchase program. This transaction, deemed an 'accretive use of capital' by the CFO, occurs amidst the company's strong financial health, including a healthy current ratio and 34% Q2 revenue growth with record net income. Despite robust operational performance, JPMorgan adjusted its price target slightly lower due to concerns over potential tariff impacts on insurance carrier spending, presenting a nuanced outlook for a stock InvestingPro considers undervalued after a recent decline.

Analysis

EverQuote (NASDAQ:EVER) is executing a $21 million share repurchase from its Chairman, David Blundin, at a discount of 1.75% to the recent closing price. This transaction, part of a larger $50 million buyback program, is presented by management as an accretive use of capital, enabled by the company's strong financial position, which includes a current ratio of 3.03 and a minimal debt-to-equity ratio of 0.02. This move follows a period of robust operational performance, highlighted by a 34% year-over-year revenue increase to $156.6 million in the second quarter and record net income of $14.7 million. Despite these strong fundamentals and a valuation deemed 'undervalued' by InvestingPro after a recent 7.8% stock decline, external headwinds exist. JPMorgan, while maintaining an Overweight rating, adjusted its price target down to $29.00 from $30.00, citing concerns that tariffs could dampen insurance carrier spending in the second half of the year. The insider sale by the Chairman is partially mitigated by the fact that his affiliated entities remain the largest shareholder with 56.8% voting control and are subject to a 180-day lock-up agreement.

Key Decisions for Investors

• Given the company's strong revenue growth, record profitability, and an active share repurchase program at a discount, investors could view the recent stock price weakness as a potential entry point.
• It is critical to monitor forward-looking statements from insurance carriers, as any hesitation in their spending due to tariff-related economic uncertainty represents the primary risk to EverQuote's near-term growth outlook.
• While a large insider sale is typically a caution signal, the structured nature of this repurchase and the Chairman retaining majority voting control suggests it may be an opportunistic capital management action rather than a loss of faith in the company's prospects.